Patents by Inventor Daisuke EINO

Daisuke EINO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Intratumoral vein-formation promoting agent
    Patent number: 12447165
    Abstract: Provided are agents comprising a phosphatidylcholine as an active ingredient to serve as a vein-formation promoting agent capable of promoting vein-like morphological change of tumor vessels, a vessel-diameter enlarging agent capable of enlarging the diameter of tumor vessels, a blood vessel-connection promoting agent capable of promoting connection of tumor vessels to each other without mediation of a lysophospholipid receptor, a leukocyte-infiltration promoting agent capable of promoting infiltration of leukocytes throughout a tumor region without mediation of a lysophospholipid receptor, and an antitumor immunostimulatory agent capable of promoting infiltration of leukocytes throughout a tumor region without mediation of a lysophospholipid receptor.
    Type: Grant
    Filed: June 15, 2017
    Date of Patent: October 21, 2025
    Assignee: OSAKA UNIVERSITY
    Inventors: Nobuyuki Takakura, Daisuke Eino
  • INTRATUMORAL VEIN-FORMATION PROMOTING AGENT
    Publication number: 20190328757
    Abstract: Provided are agents comprising a phosphatidylcholine as an active ingredient to serve as a vein-formation promoting agent capable of promoting vein-like morphological change of tumor vessels, a vessel-diameter enlarging agent capable of enlarging the diameter of tumor vessels, a blood vessel-connection promoting agent capable of promoting connection of tumor vessels to each other without mediation of a lysophospholipid receptor, a leukocyte-infiltration promoting agent capable of promoting infiltration of leukocytes throughout a tumor region without mediation of a lysophospholipid receptor, and an antitumor immunostimulatory agent capable of promoting infiltration of leukocytes throughout a tumor region without mediation of a lysophospholipid receptor.
    Type: Application
    Filed: June 15, 2017
    Publication date: October 31, 2019
    Applicant: OSAKA UNIVERSITY
    Inventors: Nobuyuki TAKAKURA, Daisuke EINO